A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms
Companies are aggressively touting 3D mammograms, although there鈥檚 no evidence they save lives.
FDA
341 - 360 of 471 Results
-
-
Vapers Accuse Officials Of Overreach As Investigation Into Deadly Lung Illness Lags
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.
-
Skin-Lightening Cream Put A Woman Into A Coma. It Could Happen Again.
A Sacramento woman is in a coma after using a face cream from Mexico. It is the nation鈥檚 first case of methylmercury poisoning from a cosmetic, and public health officials can do almost nothing to prevent other contaminated cosmetics from hitting the shelves.
-
At Raucous Hearing, No Unity On Vaping Issues
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
By Rachel Bluth -
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients鈥 Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication鈥檚 long production window.
-
Camouflaged Vaping Devices Are Hoodwinking Parents And Schools
The vaping hoodie. The vaping watch. The vaping phone case. Each ready to deliver a puff of nicotine (or marijuana) anywhere, anytime. The vaping market is crowded with sleek, camouflaged devices that have teachers and parents struggling to monitor illicit usage of a product that has surged in popularity among high schoolers.
-
Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
-
Purveyors Of Black-Market Pharmaceuticals Target Immigrants
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
-
Vapers Seek Relief From Nicotine Addiction In 鈥 Wait For It 鈥 Cigarettes
Even though e-cigarette makers market their products as a safer alternative to cigarettes, a growing number of vapers are trying to quit鈥 and they鈥檙e turning to cigarettes to help them.
-
KHN鈥檚 鈥榃hat The Health?鈥: Despite Booming Economy, Uninsured Rate Ticks Up
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau鈥檚 annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and 鈥渟urprise鈥 medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
-
Mysterious Vaping Lung Injuries May Have Flown Under Regulatory Radar
Doctors who saw patients with a mysterious lung illness in the past suspected vaping as the cause but didn鈥檛 know where to report such cases.
-
Shopping Abroad For Cheaper Medication? Here鈥檚 What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here鈥檚 some advice.
-
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they鈥檝e been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
-
FDA Ends Months-Long FOIA Battle Over Medical Device Failures, Says Putting Database Online ‘Satisfies’ KHN Request
KHN filed multiple Freedom of Information Act requests over months, and the FDA responded Wednesday saying the data about device malfunctions is now publicly available online.
-
Five Things We Found In The FDA鈥檚 Hidden Device Database
The Food and Drug Administration released two decades of previously hidden data containing millions of injuries or malfunctions by medical devices. Here鈥檚 what we鈥檝e learned so far.
-
FDA Overlooked Red Flags In Drugmaker鈥檚 Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
More Than Half Of Surgical Stapler Malfunctions Went To Hidden FDA Database
The FDA reveals that 56,000 malfunctions associated with surgical staplers weren鈥檛 reported through its traditional public reporting system.
By Sydney Lupkin and Christina Jewett -
Hidden Reports Masked The Scope Of Widespread Harm From Faulty Heart Device
The Food and Drug Administration allowed one company to send 50,000 reports of harm or malfunctions to an internal database even as patients worried about faulty defibrillators lodged in their hearts.
-
Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads 鈥 just like side effects.
By Julie Appleby and Sydney Lupkin